Hohl Benjamin bought ELVN
December 22, 2025 · Form 4 insider transaction
Hohl Benjamin bought 13,000 shares of Enliven Therapeutics, Inc. at $2.48 per share, a transaction worth $32.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
13,000
Price
$2.48
Total value
$32.2K
InsiderHohl Benjamin
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after36,000
OwnershipDirect
10b5-1 planNo
AmendedNo